INGN Q2 2018 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$97M+51.6% YoY

Gross Profit

$48M49.8% margin

Operating Income

$14M14.4% margin

Net Income

$15M15.0% margin

EPS (Diluted)

$0.65

QoQ Revenue Growth

+23.0%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$333M

Total Liabilities

$66M

Stockholders' Equity

$267M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$97M	$64M	+51.6%
Gross Profit	$48M	$32M	+53.5%
Operating Income	$14M	$8M	+65.0%
Net Income	$15M	$8M	+75.2%

Geographic Segments

UNITED STATES

$76M79%

Non Us

$21M21%